TY - JOUR T1 - Scleroderma--developing measures of response. JF - The Journal of Rheumatology JO - J Rheumatol SP - 2477 LP - 2480 VL - 32 IS - 12 AU - Daniel E Furst AU - Dinesh Khanna AU - Marco Mattucci-Cerinic AU - Alan J Silman AU - Peter A Merkel AU - Ivan Foeldvari AU - OMERACT 7 Special Interest Group Y1 - 2005/12/01 UR - http://www.jrheum.org/content/32/12/2477.abstract N2 - The scleroderma research community continued its focus on the development and proper validation of the outcome measures for clinical trials in scleroderma during the special interest group meeting at OMERACT 7. Deliberations focused on progress in the assessment of gastrointestinal disease, renal physiology, vascular damage, and the unique challenges inherent in studying pediatric patients with scleroderma. ER -